Table 1 Correlation between CXCL1 expression in tumour tissues from HCC patients and corresponding clinicopathologic parameters.

From: Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1β/CXCL1 signalling pathway

Factors

CXCL1 expression

 

Low(n = 30)

High(n = 21)

P-value

Sex (male/female)

28/2

19/2

1.000

Age (≤ 65/> 65 years)

24/16

17/4

1.000

AFP (low/high)

14/16

9/12

0.788

Cirrhosis (yes/no)

19/11

20/1

0.021*

Microvascular invasion (yes/no)

7/23

11/10

0.033*

  1. *P < 0.05.
Back to article page